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MiR-9, miR-153 and miR-124 are down-
regulated by acute exposure to cocaine in
a dopaminergic cell model and may
contribute to cocaine dependence
Judit Cabana-Domínguez 1,2,3,4, Concepció Arenas1, Bru Cormand 1,2,3,4 and Noèlia Fernàndez-Castillo 1,2,3,4
Abstract
Cocaine is one of the most used psychostimulant drugs worldwide. MicroRNAs are post-transcriptional regulators of
gene expression that are highly expressed in brain, and several studies have shown that cocaine can alter their
expression. In a previous study, we identified several protein-coding genes that are differentially expressed in a
dopaminergic neuron-like model after an acute exposure to cocaine. Now, we used the prediction tool WebGestalt to
identify miRNA molecules potentially involved in the regulation of these genes. Using the same cellular model, we
found that seven of these miRNAs are down-regulated by cocaine: miR-124-3p, miR-124-5p, miR-137, miR-101-3p, miR-
9-5p, miR-369-3p and miR-153-3p, the last three not previously related to cocaine. Furthermore, we found that three of
the miRNA genes that are differentially expressed in our model (hsa-miR-9-1, hsa-miR-153-1 and hsa-miR-124-3) are
nominally associated with cocaine dependence in a case–control study (2,085 cases and 4,293 controls). In summary,
we highlighted novel miRNAs that may be involved in those cocaine-induced changes of gene expression that
underlie addiction. Moreover, we identified genetic variants that contribute to cocaine dependence in three of these
miRNA genes, supporting the idea that genes differentially expressed under cocaine may play an important role in the
susceptibility to cocaine dependence.
Introduction
Cocaine is one of the most used illicit drugs and its use
is one of the major public health problems worldwide1.
However, only a subset of individuals exposed to cocaine
(around 15–16% of cocaine users) develop an addiction2.
Transcriptomic studies performed in animal models
and human brain post-mortem samples have revealed that
both acute and chronic exposure to cocaine produce
changes in the expression of genes related to diverse
functional categories, such as cell adhesion, extracellular
matrix, synaptic communication and neuroplasticity,
receptors, ion channels and transporters, oligoden-
drocytes and myelin, mitochondrial function, apoptosis
and cell death, transcription factors and signal transduc-
tion3,4. Cocaine also produces epigenetic adaptations like
changes in DNA methylation, chromatin remodeling or
alterations in miRNA regulation5–7. Both epigenetic
adaptations and changes in gene expression induced by
cocaine trigger molecular and cellular adaptations in the
central nervous system that may explain the persistence of
drug-seeking behavior, even after extended periods of
abstinence4,8–10.
The interaction between the individual’s genetic back-
ground, epigenetic factors and environment11 determine
how neuronal circuits adapt to chronic cocaine exposure,
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establishing the development of addiction in some indi-
viduals but not in others10. Cocaine dependence is one of
the most heritable psychiatric disorders (around
65–79%12–15), and some of those genetic risk factors may
lie in genes that mediate cocaine’s effects, conferring
initial vulnerability to the establishment of drug-induced
neuroadaptations.
MicroRNAs (miRNAs) are post-transcriptional reg-
ulators of gene expression that bind to target mRNAs to
inhibit translation or promote mRNA degradation. Each
miRNA can regulate the expression of hundreds of dif-
ferent mRNAs, and each mRNA species can be targeted
by several miRNAs. MiRNA regulation generates a very
complex and dynamic system that allows the cells to fine-
tune gene expression16–18. In addition to the canonical
cytoplasmic function, there is evidence that miRNAs
located in the nucleus can regulate mRNA stability in the
nucleolus and modulate alternative splicing, as well as
activate or inhibit the transcription of target genes19.
MiRNAs are very abundant in the central nervous sys-
tem, especially in the synapto-dendritic compartment,
where they control local mRNA translation in response to
neuronal activity20, which is essential for synapses devel-
opment, neuronal plasticity, memory and learning21,22. It
is known that cocaine alters miRNA expression profiles in
brain23. Using RNAseq, Eipper-Mains and collaborators
inspected cocaine-responsive miRNAs in nucleus
accumbens (NAc) and striatal post-synaptic densities
(PSDs) in chronically cocaine-treated mice. They found
several differentially expressed miRNAs, most of them
belonging to four miRNA families (miR-8, miR-7, miR-
142 and Let-7), which suggests that cocaine modulates
expression of miRNAs that have similar target genes24. In
a subsequent study, they used a list of mRNAs25 found
enriched in PSD to identify predicted targets of these
miRNAs26, using bioinformatic tools.
In a previous study we evaluated changes in gene
expression induced by acute cocaine exposure in a dopa-
minergic neuron-like model (differentiated SH-SY5Y cells).
We found differences in 756 protein-coding genes involved
in several processes with potential relevance to central
nervous system function, including regulation of tran-
scription, chromatin modification, focal adhesion and cell
projection, and neurotrophin and MAPK signaling path-
ways27. Furthermore, these genes showed an enrichment of
predicted binding sites for several miRNAs, miR-124 among
them. Based on these results, we hypothesized that the
observed changes in gene expression can be produced, in
part, by changes in miRNA expression. Here, we aimed at
validating predicted changes in miRNA expression altered
by cocaine in differentiated SH-SY5Y cells. Furthermore, we
aimed to evaluate their possible contribution to the sus-
ceptibility to cocaine dependence through a case–control
association study with common genetic variants.
Materials and methods
MiRNA selection
In a previous study27 we assessed transcriptomic
changes induced by cocaine in a human dopaminergic
neuron-like model (differentiated SH-SY5Y neuro-
blastoma cells) at 6 and 24 h after an acute 30-min
exposure to cocaine at 1 or 5 μM. We identified 756
protein-coding genes showing differential expression only
under 5 μM cocaine after 6 h (10% FDR), 337 of them
down-regulated and 419 up-regulated27. In the present
study we further evaluated the enrichment of miRNA-
binding sites among the differentially expressed genes.
We performed a “miRNAs target analysis” with the online
tool WEB-based GEne SeT AnaLysis Toolkit (WebGes-
talt, http://www.webgestalt.org/webgestalt_2013)28,29
using the default settings and considering up-regulated
and down-regulated subsets of genes separately (Supple-
mentary Table 1). We filtered the results obtained using
the following criteria: (i) miRNAs expressed in brain,
according to the miRIAD database (http://bmi.ana.med.
uni-muenchen.de/miriad/), (ii) every single miRNA has
predicted binding sites in at least 10 target genes, (iii) an
enrichment P-value <0.01. We also discarded predictions
of miRNA families due to the difficulty to validate all the
different miRNAs within them. We then prioritized
miRNAs which predicted target genes were enriched in
any biological function according to GO or KEGG, or
miRNAs with a reported relation with cocaine.
MiRNA expression
Changes in the expression of miRNA genes were tested
in new cultures of dopaminergic neuron-like cells exposed
to cocaine. SH-SY5Y cells (ATCC, LGC Standards) were
differentiated and validated as previously described27.
After an exposure to 5 µM cocaine for 30min, the med-
ium was replaced and cells were retrieved at 3 or 6 h,
performing 10 biological replicates per condition. Total
RNA including miRNAs was isolated using the miRNeasy
Micro Kit (Qiagen, Hilden, Germany). RNA concentra-
tion was determined using the NanoDrop ND-1000
spectrophotometer (NanoDrop Technologies, Termo-
Fisher Scientific Inc., Wilmington, DE, USA) and integrity
was evaluated with the Bioanalyzer 2100 platform (Agilent
Technologies, Santa Clara, CA, USA). The averaged RIN
values (RNA Integrity Number) was 9.98, being 9.8 the
lowest one.
Mature miRNAs were retrotranscribed using the
miScript II RT Kit (Qiagen) and real-time quantitative
PCR (qRT-PCR) experiments were performed with the
miScript SYBR Green PCR Kit (Qiagen) in the Light-
Cycler 480 II system (Roche Life Sciences, Branford, CT,
USA). For primers sequences, see Supplementary Table
2. To select a reference gene we tested several miRNA
genes, and compared and ranked them using the online
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tool RefFinder (http://150.216.56.64/referencegene.php?
type=reference) that integrates different computational
tools (geNorm, Normfinder, BestKeeper and the com-
parative ΔCt method). Relative quantification was per-
formed for each miRNA by normalizing the level of
expression to that of the selected reference miR-3911,
which is stable across samples.
A one-way ANOVA with Dunnett’s post hoc test was
performed to examine the gene expression changes
among groups. Previously, normality and homogeneity of
variance were ascertained in our samples using the
Shapiro–Wilk and Bartlett tests, respectively. A value of P
< 0.05 was considered to be statistically significant.
Gene networks
The differentially expressed miRNAs were subjected
to analysis of gene networks using the Ingenuity Path-
way Analysis 8.8 software (http://www.ingenuity.com/
products/ipa; Ingenuity Systems, Redwood city, CA,
USA).
Gene-based association analysis
We used MAGMA 1.05b30 to perform a gene-based
association analysis to test the contribution to cocaine
dependence susceptibility of the miRNAs which
expression is altered by cocaine. We used the summary
statistics from a GWAS meta-analysis of cocaine
dependence (Ncases= 2,085; Ncontrols= 4,293)
31, con-
sidering the SNP-wise mean model, in which the sum of
−log(SNP P-value) for SNPs located within a gene and
its regulatory regions was used as the statistic test. We
selected all miRNA genes encoding each differentially
expressed mature miRNA and the regulatory regions,
including both that of the miRNA and that of the host
protein-coding gene, identified according to histone
marks H3K4me1, H3K4me3, H3K27me3 and H3K27Ac
in UCSC Genome Browser (assembly GRCh37/hg19)32.
The gene P-value was calculated using a known
approximation of the sampling distribution33. MAGMA
accounts for gene size, number of SNPs in a gene and
linkage disequilibrium between markers (estimated
using data from 1000Genomes Phase 3, European
ancestry samples34).
Summary statistics used in this analysis derive from a
case–control GWAS meta-analysis of cocaine dependence
performed using four datasets from the dbGaP repository
(https://www.ncbi.nlm.nih.gov/gap) under the project
10608. All cases used met DSM-IV criteria for cocaine
dependence, although most of them are also dependent to
other drugs of abuse. Control individuals were taken from
the general population, except for those of the SAGE
sample, where drug abuse or dependence were formally
discarded31.
Results
In a previous study we identified 756 protein-coding
genes showing differential expression in a dopaminergic
neuron-like model after an acute exposure to cocaine27.
Here we evaluated whether these changes in gene
expression might be produced by changes in miRNA
expression induced by cocaine.
Using the online prediction tool WebGestalt we tested
enrichment for miRNA-binding sites in the differentially
expressed mRNAs. We found enrichment for 6 miRNAs
in the subset of down-regulated target genes, and 84
miRNAs for the up-regulated ones (Supplementary Table
1). After filtering them according to the criteria described
above (see Materials and methods), we selected 11 miR-
NAs (hsa-miR-9-3p, hsa-miR-9-5p, hsa-miR-101-3p, hsa-
miR-105-5p, hsa-miR-124-3p, hsa-miR-124-5p, hsa-miR-
137, hsa-miR-153-3p, hsa-miR-181-5p, hsa-miR-186-5p
and hsa-miR-369-3p), all of them predicted to bind up-
regulated genes in our previous study. Thus, we expected
to find these miRNAs down-regulated, as they are nega-
tive regulators of gene expression.
Since the RNA samples used in the previous work did
not contain miRNAs, we performed new experiments of
cocaine exposure in differentiated SH-SY5Y cells, to
experimentally validate changes in miRNA expression, at
3 and 6 h after 30 min of cocaine treatment at 5 µM. The
results showed that 6 h after the 30-min cocaine treat-
ment, seven out of the 11 tested miRNAs were down-
regulated, as predicted, when compared to untreated
control cells: miR-9-5p (FC=−1.49, SE= 0.19, P= 1.3e-
03), miR-101-3p (FC=−2.00, SE= 0.26, P= 0.012), miR-
124-3p (FC=−2.17, SE= 0.17, P= 1.4e-03), miR-124-5p
(FC=−1.54, SE= 0.15, P= 4e-03), miR-137 (FC=
−1.69, SE= 0.26, P= 0.015), miR-153-3p (FC=−2.94,
SE= 0.2, P= 1.3e-03) and miR-369-3p (FC=−2.22, SE
= 0.2, P= 7.6e-03) (Fig. 1). None of them showed sig-
nificant changes at 3 h after treatment, although in some
cases a decreasing trend was observed (Fig. 1). The other
four miRNAs did not change their expression significantly
(Fig. 1).
Then, we evaluated the relationship between these
miRNAs and other genes by gene network analysis. First,
we inspected the connections between the identified
down-regulated miRNAs and their up-regulated target
mRNA (predicted to contain miRNA-binding sites). We
found five out of the seven differentially expressed miR-
NAs connected with 17 up-regulated genes in a network
related to “Developmental Disorder, Ophthalmic Disease,
Organismal Injury and Abnormalities” (score= 41; Fig.
2a). Second, we inspected how these differentially
expressed miRNAs are connected with other genes in the
genome and found that all seven miRNAs were present
and highly connected in a network involved in “Cell-To-
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Cell Signaling and Interaction, Nervous System Devel-
opment and Function, Inflammatory Disease” (score= 21;
Fig. 2b), including target genes such as FOS, CASP3 and
RYR3.
Finally, we evaluated the possible contribution of these
miRNAs to cocaine dependence susceptibility by asses-
sing the presence of common genetic risk variants for
cocaine dependence within the genes encoding these
miRNAs. Thus, we performed a gene-based association
analysis in a sample of 2,085 cocaine-dependent indivi-
duals and 4,293 controls. Interestingly, three miRNA
genes were found nominally associated with cocaine
dependence: hsa-miR-9-1 (P= 0.011), hsa-miR-153-1 (P
= 0.036) and hsa-miR-124-3 (P= 0.042) (Table 1). These
genes encode mature miRNAs that are highly connected
in the identified networks (Fig. 2a, b).
Discussion
In this study we explored the possibility that cocaine-
induced changes in gene expression found in a previous
study of our group may be triggered by changes in the
expression of miRNA molecules.
We used prediction tools to identify miRNAs that
potentially regulate protein-coding genes which expres-
sion is altered by cocaine according to a previous study by
our group in a dopaminergic cell model27. Seven of the 11
miRNAs selected were significantly down-regulated after
an acute exposure to cocaine (miR-9-5p, miR-101-3p,
miR-124-3p, miR-124-5p, miR-137, miR-153-3p and miR-
369-3p), consistent with the predictions and with the up-
regulation of their target genes. Moreover, through gene
network analyses, we correlated down-regulated miRNAs
with the up-regulated target genes identified in our pre-
vious study. This network includes several genes pre-
viously associated with cocaine dependence, such as PKC,
encoding an enzyme involved in cocaine-induced neuro-
plasticity35–37, or JUN, an early immediate gene (EIG) that
activates transcription through heterodimerization at AP-
1 sites38–41. Furthermore, we found interaction between
miR-124-3p and its validated target TEAD142,43, encoding
a transcription factor regulated by the Hippo pathway that
controls proliferation44. On the other hand, we performed
a network analysis to test the interaction of the seven
down-regulated miRNAs identified with all the genes in
the genome. We identified an interesting network
involved in “Cell-To-Cell Signaling and Interaction,
Nervous System Development and Function, Inflamma-
tory Disease” in which the seven differentially expressed
miRNAs are present and highly interconnected. In this
network we highlight three genes: FOS, CASP3 and RYR3.
Fig. 1 Transcription levels of all tested miRNAs determined by qRT-PCR at 3 and 6 h after a 30-min exposure to 5 µM cocaine in dopaminergic
neuron-like cells. Significant differences compared to control cells (not exposed to cocaine) normalized to miR-3911 are indicated (*P-value <0.05,
**P-value <0.01). Mean and standard deviation are shown
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Fig. 2 Gene networks involved in a) 'developmental disorder, ophthalmic disease, organismal injury and abnormalities' (score= 41) and b) 'cell-to-
cell signaling and interaction, nervous system development and function, inflammatory disease' (score= 21). The green and red nodes in the
pathway indicate the down- and up-regulated genes, respectively
Cabana-Domínguez et al. Translational Psychiatry  (2018) 8:173 Page 5 of 8
FOS is a very important EIG highly associated with
cocaine dependence, as recently reviewed elsewhere45.
CASP3 encodes a pro-apoptotic protein involved in
cocaine-mediated cell death that is very important for
both adult and fetal cocaine neurotoxicity46,47. And RYR3,
a member of the RyR family involved in cocaine-induced
place preference regulated by dopamine D1 receptor48.
RYR3 is a highly confident predicted target of miR-124-3p
and miR-153-3p according to different online miRNA:
mRNA prediction tools like miRBD, DianaT, TargetScan,
and PicTar. Furthermore, RYR3 was found up-regulated
in dopaminergic-enriched regions from substantia nigra
and ventral tegmental area in post-mortem brain samples
from cocaine abusers38, as well as in our previous study
on dopaminergic neuron-like cells treated with cocaine27.
Some of the miRNAs reported in the present study had
also been found down-regulated by cocaine in previous
works. For example, miR-124 is down-regulated in the
NAc of mice chronically exposed to cocaine49 and in
neuronal cell cultures (Be(2)-M17 and SH-SY5Y) treated
with cocaine50. Moreover, overexpression of this gene in
NAc attenuates cocaine-induced place preference in
mice51. On the other hand, miR-137 and miR-101 are
down-regulated in the NAc of cocaine self-administrated
rats compared to controls52. This is the first time that
miR-9-5p, miR-369-3p and miR-153-3p are found down-
regulated after cocaine treatment. MiR-9 is one of the
most highly expressed miRNAs in the adult vertebrate
brain and it plays an important role in brain development,
neurogenesis, synaptic plasticity and memory53–57. Fur-
thermore, a recent study associated fetal alcohol exposure
with an increase of miR-9 in the pituitary, which represses
the D2r gene and its spliced variant D2s58. The miR-369 is
located in the miR379–410 cluster, which contains 38
miRNAs involved in neuronal development and func-
tion59. MiR-369-3p regulates the expression of Ncad,
Adam19, and TrappC8, very important in neurogenesis
and neuronal migration60. Finally, miR-153 inhibits Cac-
na1c to suppress neuroendocrine secretion (insulin and
dopamine)61.
Interestingly, three of the genes encoding differentially
expressed mature miRNAs (hsa-miR-9-1, hsa-miR-153-1
and hsa-miR-124-3) were found to be nominally asso-
ciated with cocaine dependence in this study. Previous
studies had reported genes which expression is altered by
cocaine and that also carry risk variants for cocaine
dependence, or viceversa (NFAT5, PLCB1 and
NTNG1)27,62,63. The findings in the present study, toge-
ther with the previous ones, support the hypothesis that
genes up-regulated or down-regulated by cocaine may
also contribute to the susceptibility to cocaine
dependence.
Strengths and limitations of the present study should be
discussed. Our study was performed in a dopaminergic
neuron-like model, from a tumor cell line, which perfor-
mance may differ from the events that take place in the
Table 1 Results of miRNA gene-based association analysis of common genetic variants in a GWAS meta-analysis of
cocaine dependence in individuals of European ancestry
Gene ID Coordinatesa N SNPs ZSTAT P-value SNP ID Risk allele SNP P-value
hsa-miR-101-1 chr1:65523406-65534997 19 0.2260 0.4105 rs486378 G 0.0420
hsa-miR-101-2 chr9:4828718-4857394 146 0.4890 0.3123 rs7870037 A 0.0113
hsa-miR-124-1 chr8:9760113-9764675 6 −0.8845 0.8117 rs62489494 C 0.7111
hsa-miR-124-2 chr8:65283014-65291854 17 0.3783 0.3525 rs190938 G 0.0518
hsa-miR-124-3 chr20:61804035-61811005 18 1.7294 0.0418 rs76137972 G 0.0342
hsa-miR-137 chr1:98509277-98521215 30 −0.1075 0.5428 rs12744323 C 0.1661
hsa-miR-153-1 chr2:220158748-220161492 8 1.7939 0.0364 rs6436132 T 0.0178
hsa-miR-153-2 chr7:157362028-157377114 38 −0.7436 0.7714 rs221296 A 0.2219
hsa-miR-153-2_HGb chr7:158377426-158412766 123 0.6251 0.2659 rs12670306 A 0.0221
hsa-miR-369 chr14:101522238-101541542 78 0.8836 0.1884 rs12431682 T 5.3E-03
hsa-miR-9-1 chr1:156389579-156394148 5 2.2778 0.0113 rs78605853 G 6.0E-03
hsa-miR-9-2 chr5:87957415-87991755 57 0.6955 0.2433 rs201864123 G 0.0484
hsa-miR-9-3 chr15:89899916-89911697 27 −0.6557 0.7440 rs961288 C 0.4393
Analysis performed using 2,085 cases and 4,293 controls
aGene coordinates based on GRCh37/hg19. NSNPs: number of SNPs per region included in the gene-based analysis; ZSTAT: the Z-value for the gene; SNP ID: SNP with
lowest P-value
bPromoter region of miR-153-2 host gene (PTPRN2). In bold, nominally associated genes
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brain. However, we were able to detect previously
described miRNAs that had shown down-regulation by
cocaine in mice, and three new miRNAs. On the other
hand, three genes encoding these altered miRNAs were
found to carry genetic variants nominally associated with
cocaine dependence in human samples, despite the rela-
tively small sample size of the meta-analysis used.
Increasing the number of individuals of this study may
increase the strength of the associations. Finally, it is
important to note that, although many tools/databases are
available to predict mRNA:miRNA interactions, the
overlap between the outputs is often very low17, so it is
important to validate them. Here, we demonstrated that
WebGestalt is a very useful tool to identify enrichment of
miRNA-binding sites in a list of potential target genes,
since we could validate changes in the expression of 7 out
of 11 predicted miRNAs. This strategy was previously
used by others with a similar performance64,65. Further
studies are needed to validate the mRNA:miRNA inter-
actions identified.
In conclusion, we found seven miRNAs down-regulated
in dopaminergic neuron-like cells after an acute cocaine
treatment, which might regulate several protein-coding
genes previously reported to be up-regulated in this
model. Here we highlighted new miRNAs that may be
involved in cocaine-induced changes of gene expression.
Furthermore, using a GWAS meta-analysis of clinical
samples, we found association between cocaine depen-
dence and three genes encoding these differentially
expressed miRNAs. All these results support the idea that
genes which expression is altered by cocaine might play
an important role in the susceptibility to cocaine depen-
dence, and also that miRNAs may be relevant players in
modulating cocaine effects and dependence.
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